Learn Medicare's DME durability requirements and how manufacturers can build evidence to support DME classification and reimbursement.
TPT and NT-APC applications may look simple, but approval depends on understanding Medicare payment systems, pricing, coding, and adoption economics.
Discover how MCIT, TCET, TAP, and RAPID have shifted reimbursement expectations for MedTech.
CMS may eliminate the NTAP Alternative Pathway. Learn how this policy shift impacts Breakthrough Devices, reimbursement strategy, and MedTech adoption.